Structural basis for the inhibition of activin signalling by follistatin.
about
Identification and characterization of follistatin as a novel angiogenin-binding proteinMembers of the DAN family are BMP antagonists that form highly stable noncovalent dimersActivins and activin antagonists in hepatocellular carcinomaFoxL2 and Smad3 coordinately regulate follistatin gene transcriptionA silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptorStructural and biophysical coupling of heparin and activin binding to follistatin isoform functionsThe Structure of FSTL3{middle dot}Activin A Complex: DIFFERENTIAL BINDING OF N-TERMINAL DOMAINS INFLUENCES FOLLISTATIN-TYPE ANTAGONIST SPECIFICITYCharacterization of the Structural Features and Interactions of Sclerostin: MOLECULAR INSIGHT INTO A KEY REGULATOR OF Wnt-MEDIATED BONE FORMATIONSolution Structure of Factor I-like Modules from Complement C7 Reveals a Pair of Follistatin Domains in Compact Pseudosymmetric ArrangementThe structure of myostatin:follistatin 288: insights into receptor utilization and heparin bindingTernary Complex of Transforming Growth Factor- 1 Reveals Isoform-specific Ligand Recognition and Receptor Recruitment in the SuperfamilyStructure of Myostatin·Follistatin-like 3An Activin A/BMP2 Chimera, AB204, Displays Bone-Healing Properties Superior to Those of BMP2Crystal structure of greglin, a novel non-classical Kazal inhibitor, in complex with subtilisinThe clip-segment of the von Willebrand domain 1 of the BMP modulator protein Crossveinless 2 is preformedA Smad-binding element in intron 1 participates in activin-dependent regulation of the follistatin geneIncomplete penetrance and phenotypic variability characterize Gdf6-attributable oculo-skeletal phenotypesStructure of Gremlin-1 and analysis of its interaction with BMP-2Structural basis for potency differences between GDF8 and GDF11.Tsukushi modulates Xnr2, FGF and BMP signaling: regulation of Xenopus germ layer formationMolecular profiling of conjunctival epithelial side-population stem cells: atypical cell surface markers and sources of a slow-cycling phenotypeActivin/Nodal inhibition alone accelerates highly efficient neural conversion from human embryonic stem cells and imposes a caudal positional identity.ALK1 signaling inhibits angiogenesis by cooperating with the Notch pathway.Inhibin at 90: from discovery to clinical application, a historical reviewOn the difficulty of increasing dental complexity.Activins and follistatins: Emerging roles in liver physiology and cancerMatrilin-3 inhibits chondrocyte hypertrophy as a bone morphogenetic protein-2 antagonist.Retinoid-independent motor neurogenesis from human embryonic stem cells reveals a medial columnar ground state.The Local Control of the Pituitary by Activin Signaling and Modulation.An integrated gene regulatory network controls stem cell proliferation in teeth.The structures that underlie normal reproductive function.Substantial Increases Occur in Serum Activins and Follistatin during Lung Transplantation.Cell-type specific modulation of pituitary cells by activin, inhibin and follistatin.Characterization of follistatin-type domains and their contribution to myostatin and activin A antagonism.Follistatin attenuates radiation-induced fibrosis in a murine modelThe immunoregulatory and fibrotic roles of activin A in allergic asthmaInvestigating the utility of human embryonic stem cell-derived neurons to model ageing and neurodegenerative disease using whole-genome gene expression and splicing analysis.Integrated expression analysis of muscle hypertrophy identifies Asb2 as a negative regulator of muscle mass.Structure and activation of pro-activin ARegulation of myogenic differentiation by androgens: cross talk between androgen receptor/ beta-catenin and follistatin/transforming growth factor-beta signaling pathways.
P2860
Q24299922-CCA72184-6105-475A-83BA-7E12033693B0Q24300782-08DE8355-A42D-47C0-AB7D-9BA538855E3AQ24646221-4982FD3F-7187-45CF-B0F9-5BD2858BD9D1Q24655444-6498D278-E6C9-422D-AAA9-C52466659C52Q27643809-FD5368BE-36DC-45C0-B6D8-31916F222EDAQ27644355-1167D5F5-424C-4900-9AA4-AA5826519B4FQ27651961-1231540E-23B7-46AE-A0BA-5AF97A190FD3Q27653715-BEFE4C84-1CBB-4A17-AFE9-F395AFCA7ECAQ27655389-DB731A13-DE34-4204-A87F-9392C025A486Q27656789-8843A906-CB0C-4B44-99F8-01A80F61CABCQ27660131-B3CE0CE7-AF30-4889-86FA-F29F06B3A53AQ27675374-649C102A-2F4B-490B-B30A-0F840B6420C2Q27682737-5A58F14F-CE44-4443-A8B2-93A19C56FBFCQ27682860-423A207A-9D31-485F-AC94-B49EC6D3D626Q27686823-080FD402-6851-4E7D-ACEE-CEA00E888D96Q28264153-DDC4AED0-352F-4E5D-8FCB-00F13E1EC553Q28306123-15DF3D0D-BA4A-4E25-AE0D-B93F92A2DF09Q30090218-A8AC65C9-1743-47FB-B650-9A2AAB4C3427Q31813087-A392A0A1-35A3-4B95-9098-AA8B9630024AQ33302102-B5EB90CF-0397-4110-84AE-8DD7B9375BFFQ33422792-ADDF0609-7AF8-47FB-A86D-542F0CDC5067Q33508812-3E09E10A-793F-4C18-842C-511497C86A04Q33719706-D547182A-8AED-4F56-9C7C-A0975D692140Q34204531-89ABEE31-F493-4815-B9FB-FDFEAE50387EQ34259478-DA76519D-30EE-484E-8A6B-D08B1425B20FQ34391497-307D5467-02AF-458F-A637-1AF901363EF9Q34683323-D1089C77-E9CA-4F9E-874B-6E3492873530Q34768963-C000AD1E-C53B-4CF1-9409-A8521E0B0F05Q35214837-71C10796-8425-423A-ADDF-7D9E443E457FQ35829857-2277A30B-E61F-4499-BCB8-2A5F51CEEA3FQ35891468-8EBBA9BB-BDC4-467E-BDB7-991C29F3E3C1Q35907211-93AB865E-6951-42A8-8511-376B6A98FFBDQ36007410-41F1488D-A887-4E38-97BD-BC7077E0F9EEQ36065507-94C9498E-FC53-454A-934D-D0BB9DC950C2Q36310562-F882295C-BF11-4060-8AFE-D78B18ADC88DQ36393944-699629BA-665B-4B46-8D5D-F108C8131C22Q36417107-5D40AFE7-2A8F-495D-BDB2-74C356B08C1DQ36890245-E184ABE9-2EA9-432C-9AE5-E2AD52880F83Q37063322-A83143F7-A872-4E7A-9391-1AAD00337ADFQ37125927-5E7028FD-4B3D-495D-8189-222C4598CB9A
P2860
Structural basis for the inhibition of activin signalling by follistatin.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Structural basis for the inhibition of activin signalling by follistatin
@nl
Structural basis for the inhibition of activin signalling by follistatin.
@ast
Structural basis for the inhibition of activin signalling by follistatin.
@en
Structural basis for the inhibition of activin signalling by follistatin.
@en-gb
type
label
Structural basis for the inhibition of activin signalling by follistatin
@nl
Structural basis for the inhibition of activin signalling by follistatin.
@ast
Structural basis for the inhibition of activin signalling by follistatin.
@en
Structural basis for the inhibition of activin signalling by follistatin.
@en-gb
prefLabel
Structural basis for the inhibition of activin signalling by follistatin
@nl
Structural basis for the inhibition of activin signalling by follistatin.
@ast
Structural basis for the inhibition of activin signalling by follistatin.
@en
Structural basis for the inhibition of activin signalling by follistatin.
@en-gb
P2093
P2860
P50
P3181
P356
P1433
P1476
Structural basis for the inhibition of activin signalling by follistatin
@en
P2093
Adrian E Harrington
Marko Hyvönen
Samantha A Morris-Triggs
P2860
P304
P3181
P356
10.1038/SJ.EMBOJ.7601000
P407
P577
2006-02-16T00:00:00Z